Sutimlimab (Anti-C1s)

Sutimlimab (Anti-C1s) is a humanized monoclonal antibody that targets the C1s protein in the classical complement pathway. It can be used for the research of cold agglutinin disease. C1s is a serine protease which cleaves C4 and C2 to form the C3 convertase. MW:145.5 KD.
Supplier Selleck Chemicals
Product # A2579
Sku # A2579-1mg*5
Pricing 1mg*5, $970.00
Feedback